Sepsis is the result of a severe infection that causes over 270,000 hospital deaths annually in the United States (Centers for Disease Control, 2016). Neutropenic patients are significantly more susceptible to infection and mortality due to their lack of immune protection from pathogens (Kochanek et al., 2019). There are no neutropenic-specific management guidelines provided by the Surviving Sepsis campaign. The hypotension support guidelines in the Surviving Sepsis Campaign provides specific instructions to rapidly infuse 30mL/kg of crystalloids and initiate norepinephrine (vasopressor) if the mean arterial pressure (MAP) drops below 65. These parameters are not always followed for various reasons such as provider preference, intensive care availability and central venous access. This survey will investigate providers? sepsis management tendencies based on hypothetical patient features, neutropenia and clinical data.